In 2011, the Bohn lab pointed out antinociception versus both of those chemically induced and inflammation-derived pain, and experiments indicated lack of opioid receptor modulation, but were being not able to determine a specific target. "We verified that conolidine binds for the newly determined opioid receptor ACKR3, although demonstrating https://lechk467icz3.wikigiogio.com/user